Summary
Global gene expression profiling studies conducted over the last couple of years have shown that molecular profiling of breast cancers can be used to identify clinically and genetically significant subtypes of breast carcinomas and subgroups of patients with different prognosis or disease outcome, and to predict therapeutic response to both endocrine and chemotherapeutic drugs. We studied one particularly aggressive form of locally advanced breast cancer, namely inflammatory breast cancer (IBC) using cDNA micro-arrays. We demonstrated that IBC is characterized by a different gene expression profile, not related to any of the previously identified breast cancer subtypes. This gene expression profile revealed potential therapeutic targets, such as the transcription factor NF-κB.
Gene expression analysis using cDNA microarrays is a technique to simultaneously analyze the expression of thousands of genes. cDNA fragments of these genes are present in spots at the surface of a glass slide. These cDNA fragments will bind to fluorescently labeled RNA molecules during hybridization. Hence, the spot containing the hybridized RNA molecules will produce a fluorescent signal proportional to the amount of RNA molecules present in sample. This fluorescent signal is a measure for gene expression. Using cDNA microarrays, complex patterns of gene expression can be deciphered.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Dumitrescu, R.G., and Cotarla, I. (2005) Understanding breast cancer risk – where do we stand in 2005? J Cell Mol Med 9, 208–221.
Key, T.J., Verkasalo, P.K., and Banks, E. (2001) Epidemiology of breast cancer Lancet Oncol 2, 133–140.
Hedenfalk, I.A. (2006) Gene expression profiling can distinguish tumor subclasses of breast carcinomas, in Gene Expression Profiling by Microarrays: Clinical Implications (Hofmann, W.K., ed.), Cambridge University Press, Cambridge, UK, pp. 132–161.
Perou, C.M., S ø rlie, T., Eisen, M.B., van de Rijn, M., Jeffrey, S.S., Rees, C.A., et al. (2000) Molecular portraits of human breast tumours. Nature 406, 747–752.
Hedenfalk, I., Duggan, D., Chen, Y., Rad-macher, M., Bittner, M., Simon, R., et al. (2001) Gene-expression profiles in hereditary breast cancer. N Engl J Med 344, 539–548.
Gruvberger, S., Ringner, M., Chen, Y., Pana-vally, S., Saal, L.H., Borg, A., et al. (2001) Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns. Cancer Res 16, 5979–5984.
Hedenfalk, I., Ringner, M., Ben-Dor, A., Yakhini, Z., Chen, Y., Chebil, G., et al. (2003) Molecular classification of familial non-BRCA1/BRCA2 breast cancer. Proc Natl Acad Sci U S A 100, 2532–2537.
Sorlie, T., Perou, C.M., Tibshirani, R., Aas, T., Geisler, S., Johnsen, H., et al. (2002) Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A 98, 10869–10874.
van 't Veer, L.J., Dai, H., van de Vijver, M.J., He, Y.D., Hart, A.A., Mao, M., et al. (2002) Gene expression profiling predicts clinical outcome of breast cancer. Nature 415, 530–536.
van de Vijver, M.J., He, Y.D., van ' t Veer, L.J., Dai, H., Hart, A.A., Voskuil, D.W., et al. (2002) A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 347, 1999–2009.
Chang, J.C., Wooten, E.C., Tsimelzon, A., Hilsenbeck, S.G., Gutierrez, M.C., Elledge, R., et al. (2003) Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer. Lancet 362, 362–369.
Ma, X.J., Wang, Z., Ryan, P.D., Isakoff, S.J., Barmettler, A., Fuller, A., et al. (2004) A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen. Cancer Cell 5, 607–616.
Paik, S., Shak, S., Tang, G., Kim, C., Baker, J., Cronin, M., et al. (2004) A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med 351, 2817–2826.
Iwao-Koizumi, K., Matoba, R., Ueno, N., Kim, S.J., Ando, A., Miyoshi, Y., et al. (2005) Prediction of docetaxel response in human breast cancer by gene expression profiling. J Clin Oncol 23, 422–431.
Jansen, M.P., Foekens, J.A., van Staveren, I.L., Dirkzwager-Kiel, M.M., Ritstier, K., Look, M.P., et al. (2005) Molecular classification of tamoxifen-resistant breast carcinomas by gene expression profiling. J Clin Oncol 23, 732–740.
Van Laere, S.J., Van der Auwera, I., Van den Eynden, G.G., Fox, S.B., Bianchi, F., Harris, A.L., et al. (2005) Distinct molecular signature of inflammatory breast cancer by cDNA micro-array analysis. Breast Cancer Res Treat 93, 237–246.
Van Laere, S.J., Van den Eynden, G.G., Van der Auwera, I., Vandenberghe, M., van Dam, P., Van Marck, E.A., et al. (2006) Identification of cell-of-origin breast tumour subtypes in inflammatory breast cancer by gene expression profiling. Breast Cancer Res Treat 95, 243–255.
Van Laere, S.J., Van der Auwera, I., Van den Eynden, G.G., Elst, H.J., Weyler, J., Harris, A.L., et al. (2006) Nuclear factor-kappaB signature of inflammatory breast cancer by cDNA microarray validated by quantitative real-time reverse transcription-PCR, immunohistochem-istry, and nuclear factor-kappaB DNA-binding. Clin Cancer Res 12, 3249–3256.
Van Laere, S.J., Van der Auwera, I., Van den Eynden, G.G., van Dam, P., Van Marck, E.A., Vermeulen, P.B., et al. (2007) NF-kB activation in inflammatory breast cancer is associated with oestrogen receptor downregulation, secondary to EGFR and/or ErbB2 overexpres-sion and MAPK hyperactivation. Br J Cancer 97, 659–669.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Laere, S.J.V., Vermeulen, P.B., Dirix, L.Y. (2009). cDNA Microarray Analysis of Inflammatory Breast Cancer Signatures. In: Kozlov, S.V. (eds) Inflammation and Cancer. Methods in Molecular Biology™, vol 512. Humana Press. https://doi.org/10.1007/978-1-60327-530-9_6
Download citation
DOI: https://doi.org/10.1007/978-1-60327-530-9_6
Publisher Name: Humana Press
Print ISBN: 978-1-60327-529-3
Online ISBN: 978-1-60327-530-9
eBook Packages: Springer Protocols